09 January,2021 07:01 AM IST | Mumbai | Partnered Content
Dr Amit Gawande
Dr Amit Gawande is one of the most promising Pulmonologists in Mumbai with distinction in dealing with ILD, COPD, Asthma and TB. He is the Head of ICU at Sujay Hospital and Chief Pulmonologist.
Dr Gawande is the founder of 'The Lung Health Centre'.
Dr Gawande was recently awarded as a "Frontline Warrior" for his extensive work with post Covid Fibrosis and it's Sequelae.
This COVID Pandemic has taken a lot from all of us in the world, and we are still not seeing the end of this tunnel. Since its inception there have been many questions and confusions about this vaccine. We still don't have all the information but I will try to answer all these questions to the best of my knowledge.
ALSO READ
Stopped manufacturing, supply of additional Covishield doses: Serum Institute
Rheumatic disease risk high up to 1 year post a Covid infection: Study
Covid virus persists in ear for a month post infection: Study
Even mild Covid can affect sleep quality Study
Even mild Covid can affect sleep quality Study
The government is in process of making protocols for distribution so we should see it in about 2 months for general public.
Yes, I recommend that everyone should take it. It will have more benefits for the population with minimal risks.
The Frontline workers and staff, civil servants, police, army, politicians and their relatives will likely get it first.
The safety and efficacy of the vaccine has been thoroughly examined by drug regulatory committee of India.
Most common side effects observed and reported so far are mild fever, local pain, body aches.
Two doses given 28 days apart.
Yes, it will create a better antibody protection against the virus.
No, it may not help with an active infection but it is preferable to take the vaccine after 2-3 weeks post infection.
Unfortunately, no company has yet tested the vaccine in pregnancy. Also, CDC has advised against giving the vaccine to pregnant and lactating mothers as of now.
Yes, it will definitely help people in immunocompromised state to have better immunity and protection against COVID.
Best protection will mostly start 2 weeks after the second dose. Its efficacy is claimed to be around 70-90% but studies are still underway.
It's too soon to predict that. Studies are underway, as the vaccine reaches the masses, we will have more information and clarity of the matter.
No, not as of now. It would be wise to continue to wear masks until we have studies of post vaccination antibody response.
Always remember...
No vaccine gives 100% protection.
Please continue to wear mask, observe physical distance and sanitize hands for some more time.Stay safe.
Dr. Amit P Gawnde
Consultant Pulmonologist
Critical Care Specialist
Sujay Hospital (Head Of ICU)
www.thelunghealthcentre.in
Tel - 9619514323
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.